(PDF) P2.01-074 Wait and See: A Favorable Alternative for

P2.01-074 Wait and See: A Favorable Alternative for R-M1a and S-M1a NSCLC Patients

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2017.09.1175

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

November 1, 2017

Authors

Publisher

Elsevier BV

Related search

R-S and S(-O)-R: Alternative Designs for Neural Networks.

Journal of the Experimental Analysis of Behavior

Behavioral Neuroscience

Cognitive Psychology

English

Determination of Potential Regenerative Braking Energy in Railway Systems: A Case Study for Istanbul M1A Light Metro Line

Journal of Automation and Control Engineering

English

P2.01-95 Assesment the Fitness for Chemotherapy of NSCLC Patients Using 6MWT

Journal of Thoracic Oncology

Respiratory Medicine

English

Wait-And-See or Radical Surgery for Rectal Cancer Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy: A Cohort Study

English

P2.01-58 Demographics, Clinical Characteristics and Treatment Sequencing in Stage III Unresectable NSCLC Patients: A Cancerlinq Cohort

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-31 Updated EGFR Mutation Frequency in 1,689 NSCLC Brazilian Patients – A National-Wide Study

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-005 a Randomized Phase II Trial of Erlotinib vs S-1 in Patients With NSCLC as Third- Or Fourth-Line Therapy (HOT1002)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-18 Differential Molecular Mechanisms Associated With Dramatic and Gradual Progression in NSCLC Patients With Intrathoracic Dissemination

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated With Immunotherapy and Ramucirumab Plus Docetaxel.

Journal of Thoracic Oncology

Respiratory Medicine

English